Drug Profile
AER 271
Alternative Names: AER-271; SIM 0307; SIM-0800; SIM1910-09Latest Information Update: 28 Sep 2023
Price :
$50
*
At a glance
- Originator Aeromics
- Developer Aeromics; Simcere Pharmaceutical Group
- Class Neuroprotectants; Small molecules
- Mechanism of Action Aquaporin 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Brain oedema
Most Recent Events
- 28 Sep 2023 No recent reports of development identified for phase-I development in Brain-oedema(In volunteers) in USA (IV)
- 09 Dec 2021 Simcere Pharmaceutical Group and Aeromics plans a phase IIa proof-of-mechanism trial for Brain oedema in USA
- 06 Dec 2021 Phase-I clinical trials in Brain oedema (In volunteers) in China (IV) (NCT05200728)